Kestra Medical Technologies, Ltd. logo KMTS - Kestra Medical Technologies, Ltd.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $31.00 DETAILS
HIGH: $32.00
LOW: $30.00
MEDIAN: $31.00
CONSENSUS: $31.00
UPSIDE: 35.67%
Metric 2026 2025 2024 2023 2021 2020
Revenue
Revenue 95.1 59.8 27.8 7.6 0 0
Cost of Revenue 46.3 35.6 27.5 18.3 0 0
Gross Profit 48.9 24.2 0.4 (10.7) 0 0
Operating Expenses
R&D Expenses 19.5 15.7 15.5 15.8 18.8 22.8
SG&A Expenses 164.1 114.9 69.9 54.0 13.9 6.5
Other Expenses 0 0 0 0 0 0
Operating Expenses 183.6 130.6 85.4 69.8 32.7 29.3
Operating Income
Operating Income (134.7) (106.4) (85.1) (80.4) (32.7) (29.3)
Interest Expense 7.5 7.7 6.2 5.6 1.2 0
Interest Income 8.4 3.2 0 0 0 0
Profitability
EBITDA (150.0) (98.0) (76.3) (73.7) (32.3) (28.8)
EBIT (145.6) (105.9) (87.9) (78.6) (32.7) (29.3)
Income Before Tax (131.3) (113.7) (94.1) (84.2) (33.9) (29.3)
Income Tax Expense 0.3 0.1 0.0 0.0 0.2 0.1
Net Income (131.6) (113.8) (94.1) (84.2) (34.1) (29.5)
Per Share Data
EPS (Basic) -2.43 -5.13 -2.04 -1.75 -0.69 -0.59
EPS (Diluted) -2.43 -5.13 -2.04 -1.75 -0.69 -0.59
Shares Outstanding 58.4 49.5 49.5 49.5 49.5 49.5
Metric 2026 2025 2024 2023 2021 2020
Current Assets
Cash & Cash Equivalents 99.7 237.6 8.2 14.8 24.3 5.8
Short-Term Investments 96.7 0 0 0 0 0
Net Receivables 14.5 8.1 2.0 2.1 0 0
Inventory 6.7 6.6 3.3 2.1 0 0
Other Current Assets 3.0 1.7 0.4 (1.7) 1.3 0.2
Total Current Assets 222.4 255.3 14.9 18.4 26.2 6.2
Non-Current Assets
Property, Plant & Equipment 62.5 36.9 28.4 16.7 3.1 1.1
Goodwill 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0
Long-Term Investments 65.8 0 0 0 0 0
Other Non-Current Assets 7.9 3.5 2.7 3.5 1.2 0.6
Total Non-Current Assets 136.1 40.4 31.0 20.2 4.3 1.7
Total Assets 358.5 295.7 45.9 38.7 30.5 7.9
Current Liabilities
Account Payables 27.3 24.0 23.9 6.2 1.7 1.8
Short-Term Debt 0.0 0 0 20.4 0 0
Deferred Revenue 0 0 0 0 0 0
Other Current Liabilities 6.6 8.7 6.2 4.7 0 0
Total Current Liabilities 50.4 38.0 33.0 36.7 6.6 4.0
Non-Current Liabilities
Long-Term Debt 42.6 41.1 42.5 17.3 20.2 0
Deferred Tax Liabilities 0 0 0 0 0 0
Other Non-Current Liabilities 1.7 8.2 177.2 102.2 0.4 0
Total Non-Current Liabilities 48.4 52.4 222.4 119.5 22.1 0
Total Liabilities 98.8 90.3 255.3 156.2 28.8 4.0
Stockholders' Equity
Common Stock 58.4 51.3 0.0 0.0 0.0 0.0
Retained Earnings (651.9) (520.2) (406.4) (312.3) (170.1) (136.0)
Accumulated Other Comprehensive Income (0.2) 0 0 0 0 0
Total Stockholders' Equity 259.7 205.4 (209.4) (117.6) 1.8 3.9
Total Liabilities & Equity 358.5 295.7 45.9 38.7 30.5 7.9
Debt Metrics
Total Debt 46.8 44.3 45.2 39.1 22.8 0.5
Net Debt (52.9) (193.3) 36.9 24.3 (1.5) (5.3)
Metric 2026 2025 2024 2023 2021 2020
Operating Activities
Net Income (131.6) (113.8) (94.1) (84.2) (34.1) (29.5)
Depreciation & Amortization 8.7 8.0 11.6 4.9 0.4 0.5
Stock-Based Compensation 33.6 24.3 1.5 1.2 1.9 0
Change in Working Capital (0.7) (6.2) 4.4 1.3 (0.0) (2.0)
Other Non-Cash Items 8.1 10.1 4.4 7.3 1.9 0.7
Operating Cash Flow (81.7) (77.6) (72.2) (69.6) (29.9) (30.3)
Investing Activities
Capital Expenditure (34.9) (23.6) (12.5) (15.5) (0.3) (0.2)
Acquisitions 0 0 0 0 0 0
Purchases of Investments (168.0) 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0
Other Investing Activities (0.3) 0.3 0.3 0 0.0 0
Investing Cash Flow (203.3) (23.3) (12.2) (15.5) (0.3) (0.2)
Financing Activities
Net Debt Issuance 0 0 5.9 (5.3) 20 0
Stock Repurchased 0 0 0 0 0 0
Dividends Paid (0.3) (1.7) (0.8) (0.7) (0.2) (0.2)
Other Financing Activities (1.9) 12.7 (2.4) 0 29.0 30.4
Financing Cash Flow 147.1 330.3 77.7 96.1 48.8 30.2
Cash Position
Net Change in Cash (137.9) 229.3 (6.7) 11.0 18.6 (0.3)
Cash at Beginning 237.9 8.6 15.3 4.3 6.3 6.6
Cash at End 100.0 237.9 8.6 15.3 24.9 6.3
Free Cash Flow (116.6) (101.2) (84.7) (85.1) (30.2) (30.5)
Key Metrics 2026 2025 2024 2023 2021 2020
Income Statement
Revenue 95.1 59.8 27.8 7.6 0 0
Gross Profit 48.9 24.2 0.4 (10.7) 0 0
Operating Income (134.7) (106.4) (85.1) (80.4) (32.7) (29.3)
Net Income (131.6) (113.8) (94.1) (84.2) (34.1) (29.5)
EPS (Diluted) -2.43 -5.13 -2.04 -1.75 -0.69 -0.59
Balance Sheet
Cash & Equivalents 99.7 237.6 8.2 14.8 24.3 5.8
Total Assets 358.5 295.7 45.9 38.7 30.5 7.9
Total Debt 46.8 44.3 45.2 39.1 22.8 0.5
Stockholders' Equity 259.7 205.4 (209.4) (117.6) 1.8 3.9
Cash Flow
Operating Cash Flow (81.7) (77.6) (72.2) (69.6) (29.9) (30.3)
Capital Expenditure (34.9) (23.6) (12.5) (15.5) (0.3) (0.2)
Free Cash Flow (116.6) (101.2) (84.7) (85.1) (30.2) (30.5)